Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells.

Literature DB >> 20679581

Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells.

Nicholas J Leeper¹, Arwen L Hunter, John P Cooke.

Abstract

Entities: CellLine Chemical Disease Gene Species

Mesh：

Year: 2010 PMID： 20679581 PMCID： PMC2920605 DOI： 10.1161/CIRCULATIONAHA.109.881441

Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690

× No keyword cloud information.

97 in total

1. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

Authors: Gerd P Meyer; Kai C Wollert; Joachim Lotz; Jan Steffens; Peter Lippolt; Stephanie Fichtner; Hartmut Hecker; Arnd Schaefer; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal: Circulation Date: 2006-03-06 Impact factor: 29.690

2. A novel small-diameter vascular graft: in vivo behavior of biodegradable three-layered tubular scaffolds.

Authors: Liang Zhang; Jianye Zhou; Qingping Lu; Yingjie Wei; Shengshou Hu
Journal: Biotechnol Bioeng Date: 2008-03-01 Impact factor: 4.530

3. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors: Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal: Cell Stem Cell Date: 2007-06-07 Impact factor: 24.633

4. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors: Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal: N Engl J Med Date: 2006-09-21 Impact factor: 91.245

5. Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb.

Authors: Claudio Napoli; Sharon Williams-Ignarro; Filomena de Nigris; Gaetano de Rosa; Lilach O Lerman; Bartolomeo Farzati; Angelo Matarazzo; Giacomo Sica; Chiara Botti; Andrea Fiore; Russell E Byrns; Daigo Sumi; Vincenzo Sica; Louis J Ignarro
Journal: Proc Natl Acad Sci U S A Date: 2005-11-14 Impact factor: 11.205

6. Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial).

Authors: Hung-Fat Tse; Sukumaran Thambar; Yok-Lam Kwong; Philip Rowlings; Greg Bellamy; Jane McCrohon; Paul Thomas; Bruce Bastian; John K F Chan; Gladys Lo; Chi-Lai Ho; Wing-Sze Chan; Raymond Y Kwong; Anthony Parker; Thomas H Hauser; Jenny Chan; Daniel Y T Fong; Chu-Pak Lau
Journal: Eur Heart J Date: 2007-11-05 Impact factor: 29.983

7. Induced pluripotent stem cells generated without viral integration.

Authors: Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal: Science Date: 2008-09-25 Impact factor: 47.728

8. Reprogramming of human somatic cells to pluripotency with defined factors.

Authors: In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal: Nature Date: 2007-12-23 Impact factor: 49.962

Review 9. Stem cell therapy for vascular disease.

Authors: Benjamin Adams; Qingzhong Xiao; Qingbo Xu
Journal: Trends Cardiovasc Med Date: 2007-10 Impact factor: 6.677

10. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors: Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal: Nat Biotechnol Date: 2007-11-30 Impact factor: 54.908

79 in total

1. Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium.

Authors: Ann C Gaffey; Minna H Chen; Chantel M Venkataraman; Alen Trubelja; Christopher B Rodell; Patrick V Dinh; George Hung; John W MacArthur; Renganaden V Soopan; Jason A Burdick; Pavan Atluri
Journal: J Thorac Cardiovasc Surg Date: 2015-07-17 Impact factor: 5.209

Review 10. Patient-specific computational modeling and magnetic nanoconstructs: tools for maximizing the efficacy of stem cell-based therapies.

Authors: Paolo Decuzzi
Journal: Methodist Debakey Cardiovasc J Date: 2013 Oct-Dec

Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells.

1. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

2. A novel small-diameter vascular graft: in vivo behavior of biodegradable three-layered tubular scaffolds.

3. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

4. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

5. Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb.

6. Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial).

7. Induced pluripotent stem cells generated without viral integration.

8. Reprogramming of human somatic cells to pluripotency with defined factors.

Review 9. Stem cell therapy for vascular disease.

10. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

1. Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium.

Review 2. Therapeutic Transdifferentiation: A Novel Approach for Ischemic Syndromes.

Review 3. Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis.

4. A compendium on peripheral arterial disease.

Review 5. Glucose metabolism, hyperosmotic stress, and reprogramming of somatic cells.

Review 6. Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine.

Review 7. Blood endothelial cells: utility from ambiguity.

Review 8. Stem Cell Sources and Graft Material for Vascular Tissue Engineering.

Review 9. Therapeutic Potential of Modulating MicroRNA in Peripheral Artery Disease.

Review 10. Patient-specific computational modeling and magnetic nanoconstructs: tools for maximizing the efficacy of stem cell-based therapies.